The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Positive Points: A programme to increase growth and productivity continues to be pursued. Last year, the company announced a 40/20/10 strategy to focus on its top 40 countries and brand categories that generate the most sales and profit, the top 20 innovations with the most growth potential and the company’s top 10 developing markets. The company increased its outlook for share repurchase to $5 billion - $6 billion, up from its earlier $4 billion - $6 billion range. P&G has implemented a $10 billion cost-cutting plan, which includes reducing headcount by 5,700 by the end of the current financial year. Procter & Gamble is a worldwide manufacturer and marketer of consumer products. The company participates in more than 40 product categories, with 300 brands sold in over 180 countries and therefore enjoys considerable diversification and geographical location. In April 2012, Procter & Gamble increased its dividend for the 56th consecutive year, making Procter & Gamble one of only six U.S. companies with this track record of dividend increases. Procter & Gamble has paid a dividend for 122 consecutive years.
Negative Points: P&G has been under pressure to improve its performance. The situation has been compounded since activist investor William Ackman, a hedge fund manager who bought a stake in the company of about 1% (valued at around $2 billion). Ackman is understood to be critical of senior management. Higher commodity costs (raw materials) remain a pressure on group profit margins. Unfavorable foreign exchange movements continue to impact. Competition across the consumer goods sector remains intense. A deterioration in the group's innovation pipeline could impact growth prospects.
Financial Highlights: The consumer products maker reported profits of $4.06 billion, up from $1.69 billion in the same quarter a year earlier. Revenue increased 2% to $22.18 billion in the period. Operating cash flow was $3.8 billion for the quarter. The Company repurchased $1.4 billion of shares during the quarter and returned $1.6 billion of cash to shareholders as dividends.
Second quarter results: Founded in 1837, Cincinnati headquartered Procter & Gamble unveiled a surge in profits to $4.06 billion, up from $1.69 billion a year earlier. The Company said it delivered broad-based organic sales growth, with all business segments increasing organic sales by 2% or more when compared with the same quarter a year ago. "Our second quarter results were at the high end of our expectations on the top-line and well ahead of forecast on operating profit, earnings per share and cash flow," said Chairman, President, and Chief Executive Officer, Bob McDonald. The company revised up its organic sales growth forecast to a range of 3% to 4% for the fiscal year from a previous range of 2% to 4%
How do i buy some? P.S why are all the buy and sells in BLACK?
and i have read all the post....thanks
Maybe we are on the same wave length?.....only thing is im 5 months late!
Positive Points: Adjusted earning per share materialised at the higher end of analyst estimates. The board maintained its organic sales growth guidance in the range of 2% to 4% for the current fiscal year. The Company also maintained its core earnings per share guidance in the range of $3.80 to $4.00, down 1% to up 4% versus prior year core EPS of $3.85. A programme to increase growth and productivity is being pursued. A strategy to maintain momentum in developing markets, strengthen its core developed market business, push its innovation product pipeline, and aggressively drive cost savings and productivity improvements is being pursued. Management plans to cut $10 billion in costs by the end of fiscal 2016. Activist investor William Ackman previously acquired about $1.8 billion worth of Procter And Gamble shares. In February, Procter And Gamble announced an agreement to sell its Snacks business to The Kellogg Company. The sale will help refocus the company’s product portfolio. The company repurchased $2.6 billion of shares during the quarter and returned $1.6 billion of cash to shareholders as dividends. In April 2012, Procter And Gamble increased its dividend for the 56th consecutive year, making Procter And Gamble one of only six U.S. companies with this track record of dividend increases. Procter And Gamble has paid a dividend for 122 consecutive years. The group enjoys considerable diversification in both product type and geographical location.
Negative Points: Both adjusted or diluted earnings per share and headline net sales declined. Management cut its earnings and sales guidance for the second time in less than two months back in June, hurt by slowing sales growth in Europe and the US The CEO back in June noted that “the company had set prices too high, failed to communicate the superiority of its products, fallen short on product innovation and allowed productivity improvement to stagnate.” Higher commodity costs (raw materials) remain a pressure on group profit margins. Unfavorable foreign exchange movements continue to impact. Competition across the consumer goods sector remains intense.
Financial Highlights: Diluted net earnings per share from continuing operations of $0.96 were reported, a decline of 5% due to non-core charges of $0.10 Organic sales grew by 2% Net sales were $20.7 billion, a fall of 4% versus the prior year period including a negative 6% impact from foreign exchange The Company repurchased $2.6 billion of shares during the quarter and returned $1.6 billion of cash to shareholders as dividends
First quarter results: Group earnings materialised at the higher end of analyst forecasts, with management maintaining both its sales and earnings guidance for the full year. Organic or like-for-like sales growth was reported, with four of its five business segments increasing versus the prior year. Management noted that it “held or grew market share in businesses representing over 45% of sales in the period, as measured on a constant currency value basis. In the US market, Procter And Gamble held or grew value share in businesses representing nearly 60% of sales.” The chief executive highlighted that Procter And Gamble was continuing to focus on executing its growth and productivity strategy.
Company overview From humble beginnings in 1837, Procter And Gamble now markets nearly 300 products to more than 5 billion consumers in around 180 countries, and ranks as one of the world's largest consumer product makers. The company's products fall into five business segments: Fabric and Home, which includes household cleaners, laundry, paper products and special fabric care; Baby and Family, including baby care, paper products and snacks and beverages; Beauty Care, which covers antiperspirants, deodorants, hair and skin care, and personal cleansing; Health Care, which includes oral care and prescription drugs; and Pet Nutrition and Care.
Positive Points: Earning per share surprised to the positive. Management plans to cut $10 billion in costs by the end of fiscal 2016. Activist investor William Ackman has recently acquired about $1.8 billion worth of P&G shares. In February, P&G announced an agreement to sell its Snacks business to The Kellogg Company. The sale will help refocus the company's product portfolio. Management announced that it would repurchase $4 billion worth of its shares this fiscal year, reversing a June announcement which said that it did not expect to do so. The group enjoys considerable diversification in both product type and geographical location. The Company returned $1.6 billion of cash to shareholders as dividends during the quarter. In April 2012, P&G increased its dividend for the 56th consecutive year, making P&G one of only six U.S. companies with this track record of dividend increases. P&G has paid a dividend for 122 consecutive years.
Negative Points: Management cut its earnings and sales guidance for the second time in less than two months back in June, hurt by slowing sales growth in Europe and the U.S. The CEO back in June noted that "the company had set prices too high, failed to communicate the superiority of its products, fallen short on product innovation and allowed productivity improvement to stagnate." During the quarter, its gross margin fell by 0.4% due mainly to higher commodity costs, unfavorable geographic and product mix and restructuring charges, which were partially offset by positive pricing and cost savings. Unfavorable foreign exchange movements reduced net sales growth by 4%. P&G currently lacks the exposure to emerging-markets which rivals such as Unilever enjoy. Competition across the consumer goods sector remains intense. the prior year.
Financial Highlights: Net sales declined by 1% to $20.2 billion. Core net earnings per share of $0.82, in line with the prior year period. Diluted net earnings per share from continuing operations were $0.74, a decline of 10% due to non-core restructuring charges. The group completed the sale of its Snacks business in the quarter. The Company returned $1.6 billion of cash to shareholders as dividends. In April 2012, P&G increased its dividend for the 56th consecutive year.
Fourth quarter results: Having only recently downgraded financial forecasts, the results materialised at the higher end of expectations. Core earnings of 82 cents per share, flat from the prior year period, surpassed the high end of a forecast management gave back in June. Net sales fell by 1% to $20.2 billion, with strength in the US dollar reducing sales by 4%. Looking forward, the board underlined the group's $10 billion cost savings programme, which it noted was "well underway." Plans to buy back $4 billion in shares this fiscal year were also highlighted, with the company back in April having increased its dividend for the 56th consecutive year.
Company overview From humble beginnings in 1837, Procter & Gamble now markets nearly 300 products to more than 5 billion consumers in 140 countries, and ranks as one of the world's largest consumer product makers. The company's products fall into five business segments: Fabric and Home, which includes household cleaners, laundry, paper products and special fabric care; Baby and Family, including baby care, paper products and snacks and beverages; Beauty Care, which covers antiperspirants, deodorants, hair and skin care, and personal cleansing; Health Care, which includes oral care and prescription drugs; and Pet Nutrition and Care.